Effect of Dexmedetomidine or Fentanyl on recovery responses to Tracheal Extubatio
Not Applicable
Completed
- Conditions
- recovery responses to Tracheal Extubation
- Registration Number
- PACTR201712002752134
- Lead Sponsor
- Faculty of medicine El minia university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Sixty patients of either sex, aged between 18-65 years old, ASA I & II, scheduled to undergo vitrectomy
Exclusion Criteria
patients with clinically significant cardiovascular, respiratory, hepatic diseases and epileptic and psychiatric patients, patient with known hypersensitivity to the study drugs, if there was pregnancy and lactation and if patient refusal
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does dexmedetomidine's alpha-2 adrenergic agonism compare to fentanyl's opioid activity in post-vitrectomy extubation recovery?
What biomarkers correlate with successful tracheal extubation outcomes in vitrectomy patients using dexmedetomidine or fentanyl?
What are the adverse event profiles of dexmedetomidine versus fentanyl during vitrectomy extubation recovery?
How do dexmedetomidine and fentanyl modulate autonomic responses during tracheal extubation in ophthalmic surgery?
Are there combination therapies with dexmedetomidine or fentanyl that enhance extubation recovery in vitrectomy procedures?